DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $81.31, for a total transaction of $609,825.00. Following the sale, the insider now owns 45,875 shares in the company, valued at approximately $3,730,096.25. This trade represents a 14.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
DocuSign Trading Down 6.7 %
DOCU stock traded down $5.16 during trading hours on Friday, hitting $72.21. 2,881,620 shares of the stock traded hands, compared to its average volume of 2,695,162. The stock has a 50-day simple moving average of $86.02 and a 200 day simple moving average of $81.98. The company has a market cap of $14.62 billion, a P/E ratio of 14.89, a P/E/G ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86.
DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company had revenue of $776.25 million during the quarter, compared to analyst estimates of $760.94 million. During the same quarter last year, the firm posted $0.76 EPS. The business's revenue for the quarter was up 9.0% on a year-over-year basis. Analysts forecast that DocuSign, Inc. will post 1.17 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of research analysts recently commented on DOCU shares. Citigroup upped their price objective on DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a research note on Friday, March 14th. JMP Securities restated a "market outperform" rating and set a $124.00 price target on shares of DocuSign in a research report on Tuesday, January 7th. Wells Fargo & Company lifted their price objective on shares of DocuSign from $70.00 to $73.00 and gave the company an "underweight" rating in a research report on Friday, March 14th. William Blair upgraded shares of DocuSign from a "market perform" rating to an "outperform" rating in a research report on Monday, March 17th. Finally, Hsbc Global Res raised DocuSign to a "moderate sell" rating in a report on Friday, December 6th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $95.83.
Get Our Latest Analysis on DocuSign
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in DOCU. Kestra Investment Management LLC bought a new stake in shares of DocuSign during the 4th quarter worth $30,000. First Horizon Advisors Inc. lifted its holdings in shares of DocuSign by 102.6% during the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock valued at $36,000 after purchasing an additional 201 shares during the last quarter. Modus Advisors LLC acquired a new position in shares of DocuSign in the 4th quarter valued at $36,000. Wood Tarver Financial Group LLC purchased a new position in DocuSign in the 4th quarter worth about $37,000. Finally, McIlrath & Eck LLC increased its stake in DocuSign by 476.0% in the 4th quarter. McIlrath & Eck LLC now owns 432 shares of the company's stock worth $39,000 after purchasing an additional 357 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.
DocuSign Company Profile
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
